Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
FMCSA Retires Legacy Systems as Motus Registration Platform Goes Live May 14
The FMCSA is retiring its legacy registration systems on May 14, 2026, launching the new Motus platform. Carriers and brokers must update their accounts to avoid manual verification delays.
Crypto Kiosk Ban Wave Grows as $389M in Scam Losses Draw Regulatory Fire
Spokane Valley has ordered all crypto ATMs removed within 30 days after police linked them to fraud and a suicide. The FBI reported $389 million in scam losses in 2025, driving a wave of state bans.
Senate Banking Committee Faces Ethics Clash Over CLARITY Act Vote
The Senate Banking Committee votes Thursday on the CLARITY Act, facing ethics disputes over Trump's crypto ties and opposition from labor unions and banks.
BAT Shares Surge on FDA Policy Shift and Legal Resolution
British American Tobacco shares rose 5.82% in London after the FDA signaled a softer stance on e-cigarette enforcement and a U.S. judge dismissed a North Korea sanctions case.
Intuitive Surgical Drops to 52-Week Low on Recall and Competition Fears
Intuitive Surgical shares fell to a 52-week low Monday after an FDA recall and lowered procedure growth forecasts, overshadowing a strong Q1 earnings beat.
Spokane Valley Bans Bitcoin ATMs Following Surge in Scam Losses
Spokane Valley has banned virtual currency kiosks after police linked them to fraud, major financial losses, and a suicide. The city council voted unanimously on May 5.
Philip Morris Rallies on FDA Nicotine Pouch Policy Shift, ZYN Ultra Hopes Revived
Philip Morris shares jumped 6.5% on Monday after the FDA eased enforcement threats against nicotine pouches, raising hopes for ZYN Ultra's U.S. launch despite ongoing regulatory uncertainty.
Super Micro Shares Dip as Legal Deadline Looms Amid AI Server Demand
Super Micro shares slid 2.2% on Monday as a May 26 lead plaintiff deadline in a securities class action nears, overshadowing a strong sales forecast and robust AI server demand.
Palantir's NHS Data Access Sparks Privacy Concerns Amid AI Stock Rally
Palantir's NHS contract grants external staff access to identifiable patient data, fueling privacy debates. Shares dip 1.1% to $136.27 amid 85% revenue growth.
Pfizer's COVID Patent Woes Persist as Investors Eye Growth Beyond Vaccines
A Delaware federal judge dismissed Acuitas Therapeutics' attempt to clear Pfizer's Comirnaty vaccine from GSK patent claims, leaving the patent dispute unresolved. Pfizer shares fell 1.42% to $25.68.
Tesla's European FSD Approval Drive Hits Regulatory Hurdles
Tesla is negotiating with Irish regulators for Full Self-Driving approval, following Dutch provisional clearance. European regulators remain divided on safety and branding issues.